| Issue Date | Title | Author(s) |
| 2025 | Avelumab Maintenance in Patients With Metastatic Urothelial Carcinoma in a Real-Life Expanded-Access Program (Eap) | Tural, Deniz; Ozkan, Oguzcan; Yaslikaya, Sendag; Tatli, Ali Murat; Akdag, Goncaguel; Demir, Hacer; Urun, Yuksel |
| 2025 | Comparison of Two Alternative Sequences With Cabazitaxel and 177lu-P in Metastatic Castration-Resistant Prostate Cancer: a Retrospective Multicenter Study (Lucas) | Bolek, Hatice; Yazgan, Sati Coskun; Ceylan, Furkan; Esteban-Villarrubia, Jorge; Arslan, Cagatay ; Kus, Tulay; Urun, Yuksel |
| 2025 | Impact of First-Line Tyrosine Kinase Inhibitor Selection on Survival Outcomes With Second-Line Nivolumab in Metastatic Renal Cell Carcinoma | Kuzu, Omer Faruk; Bolek, Hatice; Camoz, Elif Sertesen; Karakas, Hilal; Sekmek, Serhat; Sim, Saadet; Urun, Yuksel |
| 2025 | The Impact of Smoking on Nivolumab Outcomes in Renal Cell Carcinoma: Real-World Data From the Turkish Oncology Group Kidney Cancer Consortium | Camoz, Elif Sertesen; Bolek, Hatice; Kuzu, Omer Faruk; Sim, Saadet; Karakas, Hilal; Sekmek, Serhat; Urun, Yuksel |
| 2022 | Long-Term Outcome and Safety in Patients Treated With Immune Checkpoint Blockade Therapies for Urothelial Carcinoma: Experience From Real-World Clinical Practice. | Tural, Deniz; Arslan, Cagatay ; Selcukbiricik, Fatih; Olmez, Omer Fatih; Erman, Mustafa; Urun, Yuksel; Karadurmus, Nuri |
| 2025 | Navigating Second-Line Therapy in Metastatic Renal Cell Carcinoma: a Comparative Analysis of Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors: a Study of Turkish Oncology Group Kidney Cancer Consortium | Aykan, Musa Baris; Bolek, Hatice; Yekeduz, Emre; Sertesen, Elif; Tural, Deniz; Karacin, Cengiz; Urun, Yuksel |
| 2024 | Treatment Patterns and Attrition in Metastatic Renal Cell Carcinoma: Real-Life Experience From the Turkish Oncology Group Kidney Cancer Consortium (tkcc) Database | Bolek, Hatice; Sertesen, Elif; Kuzu, Omer Faruk; Tural, Deniz; Sim, Saadet; Sendur, Mehmet Ali Nahit; Urun, Yuksel; Arslan, Cagatay |
| 2025 | Uric Acid Level in Metastatic Renal Cell Carcinoma Treated With Nivolumab: a Turkish Oncology Group Kidney Cancer Consortium (TKCC) Study | Sekmek, Serhat; Bolek, Hatice; Kuzu, Omer Faruk; Camoz, Elif Sertesen; Sim, Saadet; Karakas, Hilal; Urun, Yuksel |
